According to researchers, COVID-19 patients struggling with severe neurological symptoms exhibit signs of impairment in the blood-brain barrier, and changes in brain structure depending on the severity of their symptoms.
In mouse model researchers have prompted the production of a protein that can block multiple variants of the SARS-CoV-2 virus from entering cells and causing disease.
The easing of public health measures taken to curb COVID-19 spread, which also reduced influenza activity, may enable easy transmission of both viruses, the WHO says.